Bruck Kifle

Array ( [id] => 8921018 [patent_doc_number] => 08486953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Thienopyrimidines for pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 13/060731 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28448 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7680693 [patent_doc_number] => 20100105893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHOD FOR PRODUCING epsilon-CAPROLACTAM AND METHOD FOR PRODUCING PENTASIL TYPE ZEOLITE' [patent_app_type] => utility [patent_app_number] => 12/543022 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7059 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105893.pdf [firstpage_image] =>[orig_patent_app_number] => 12543022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6376874 [patent_doc_number] => 20100076188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'NOVEL CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE' [patent_app_type] => utility [patent_app_number] => 12/542050 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14086 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076188.pdf [firstpage_image] =>[orig_patent_app_number] => 12542050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8625192 [patent_doc_number] => 08357687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => 'Macrocyclic indole derivatives useful as hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 13/058990 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19114 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657335 [patent_doc_number] => 20110306604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => '3- AND 6-QUINOLINES WITH N-ATTACHED HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/059164 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21380 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306604.pdf [firstpage_image] =>[orig_patent_app_number] => 13059164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244935 [patent_doc_number] => 08202857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => '1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1' [patent_app_type] => utility [patent_app_number] => 12/583009 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51911 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202857.pdf [firstpage_image] =>[orig_patent_app_number] => 12583009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4556665 [patent_doc_number] => RE041911 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-11-02 [patent_title] => 'Epothilone derivatives' [patent_app_type] => reissue [patent_app_number] => 12/539492 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15228 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => -51 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041911.pdf [firstpage_image] =>[orig_patent_app_number] => 12539492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4536173 [patent_doc_number] => RE041895 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-10-26 [patent_title] => 'Epothilone derivatives' [patent_app_type] => reissue [patent_app_number] => 12/539496 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15207 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => -53 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041895.pdf [firstpage_image] =>[orig_patent_app_number] => 12539496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4536156 [patent_doc_number] => RE041893 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-10-26 [patent_title] => 'Epothilone derivatives' [patent_app_type] => reissue [patent_app_number] => 12/539498 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15228 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041893.pdf [firstpage_image] =>[orig_patent_app_number] => 12539498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7741130 [patent_doc_number] => 08106187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Process for the preparation of a macrocycle' [patent_app_type] => utility [patent_app_number] => 12/462736 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14696 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106187.pdf [firstpage_image] =>[orig_patent_app_number] => 12462736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511435 [patent_doc_number] => 20110257145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'METHOD OF TREATING NEUROLOGICAL DISEASES' [patent_app_type] => utility [patent_app_number] => 13/056821 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16562 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257145.pdf [firstpage_image] =>[orig_patent_app_number] => 13056821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580976 [patent_doc_number] => 20110294859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'SUBSTITUTED PYRIDOXINE-LACTAM CARBOXYLATE SALTS' [patent_app_type] => utility [patent_app_number] => 13/056943 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9282 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294859.pdf [firstpage_image] =>[orig_patent_app_number] => 13056943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682041 [patent_doc_number] => 20100022767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'DEVELOPMENT OF A SYNTHESIS OF SYRINGOLIN A AND B AND DERIVATIVES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/508964 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5523 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022767.pdf [firstpage_image] =>[orig_patent_app_number] => 12508964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316541 [patent_doc_number] => 20090281139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS' [patent_app_type] => utility [patent_app_number] => 12/507907 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77575 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281139.pdf [firstpage_image] =>[orig_patent_app_number] => 12507907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355876 [patent_doc_number] => 20100022518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'NOVEL HETEROCYCLYL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/507858 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47847 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022518.pdf [firstpage_image] =>[orig_patent_app_number] => 12507858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527574 [patent_doc_number] => 20100015092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'QUINOXALINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/505725 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31701 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015092.pdf [firstpage_image] =>[orig_patent_app_number] => 12505725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518939 [patent_doc_number] => 07973040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/504955 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10564 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973040.pdf [firstpage_image] =>[orig_patent_app_number] => 12504955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257518 [patent_doc_number] => 20100029669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => '3-(SUBSTITUTED ETHYL)-RIFAMYCIN DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/502435 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13596 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029669.pdf [firstpage_image] =>[orig_patent_app_number] => 12502435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401759 [patent_doc_number] => 08691811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 13/129995 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14151 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83804 [patent_doc_number] => 07741338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Macrolides' [patent_app_type] => utility [patent_app_number] => 12/497728 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4920 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741338.pdf [firstpage_image] =>[orig_patent_app_number] => 12497728 [rel_patent_id] =>[rel_patent_doc_number] =>)